, Tracking Stock Market Picks
Enter Symbol:
Geron Corporation (GERN) [hlAlert]

Neutral GERN
up 12.66 %

Geron Corporation (GERN) downgraded to Neutral by Piper Jaffray

Posted on: Wednesday,  Mar 12, 2014  8:25 AM ET by Piper Jaffray

Piper Jaffray rated Neutral Geron Corporation (NASDAQ: GERN) on 03/12/2014. Previously Piper Jaffray rated Overweight Geron Corporation (NASDAQ: GERN) on 08/09/2013.,
when the stock price was $1.50. Since then, Geron Corporation has gained 12.67% as of 03/12/2014's recent price of $1.69.
If you would have followed the previous Piper Jaffray's recommendation on GERN, you would have gained 12.66% of your investment in 215 days.

Geron Corporation is a scientific research company that is developing techniques for the health services industry. Their research is currently divided in three different areas. First, they are looking into telomeres and telomerase and their roles in cellular aging and cancer. Second, they are looking pluripotent stem cells as a potential source for the manufacturing of replacement cells and tissues. Lastly, the company is researching nuclear transfer as a potential mechanism for generating genetically matched cells and tissues.

At Piper Jaffray, we understand there’s no substitute for relevant and timely research. That's why we provide: * fundamental and technical research * value-added investment ideas * market analysis With the information our research team provides, you’ll make better and more informed decisions for your portfolio.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/12/2014 8:25 AM Hold
as of 10/17/2014
1 Week   
1 Month   
3 Months   
1 YTD down  -64.34 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/9/2013 8:25 AM Buy
3/14/2013 8:25 AM Hold
1/18/2013 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy